Riskpilot← Back to searchSign inGet full accessTandlægerne i Haderslev I/S
I/SActiveCVR 39969092Torvet 3Dental practice care activities · NACE 8623Est. 20182 employees
Revenue 2025
DKK -659K
-13% vs 2024
EBITDA margin
266.2%
+1% vs 2024
Equity ratio
79.9%
Financial strength
Net profit 2025
DKK -1,8M
+1% vs 2024
| Revenue | DKK -659K | -13% |
| EBITDA | DKK -1,8M | +1% |
| Net profit | DKK -1,8M | +1% |
| Total assets | DKK 484K | +103% |
| Equity | DKK 386K | +254% |
| Employees | 2 | — |
Legal name
Tandlægerne i Haderslev I/S
CVR number
39969092
Legal form
Interessentskab
NACE code
8623 · Dental practice care activities
Founded
24. oktober 2018
Share capital
—
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Interessentskabet tegnes af den samlede direktion.
Company purpose
Interessentskabets formål er at drive tandlægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Address
Torvet 3
Phone
+4574522802
Email
mail@haderslevtand.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -756 | -831 | -760 | -753 | -659 |
| Staff expenses | -1.101 | -1.097 | -1.102 | -1.017 | -1.095 |
| EBITDA | -1.856 | -1.928 | -1.861 | -1.770 | -1.754 |
| Depreciation & amort. | -115 | -115 | -126 | -25 | -17 |
| EBIT | -1.972 | -2.043 | -1.987 | -1.795 | -1.771 |
| Net financials | -0 | -0 | 1 | 1 | 0 |
| Profit before tax | -1.972 | -2.043 | -1.986 | -1.794 | -1.771 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.972 | -2.043 | -1.986 | -1.794 | -1.771 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 396 | 267 | 409 | 239 | 484 |
| Equity | 193 | 199 | 288 | 109 | 386 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 204 | 68 | 121 | 129 | 97 |
| Total debt | 204 | 68 | 121 | 129 | 97 |
EBITDA margin
-175375800.0%
This company
15.8%
Market median
-1109973518% vs market
20212025
Equity ratio
79.9%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
-458.1%
This company
18.4%
Market median
-2590% vs market
20212025
Net profit margin
-177070800.0%
This company
8.1%
Market median
-2186059359% vs market
20212025
Asset turnover
-1.36×
This company
1.12×
Market median
-221% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MR Management | Management | 2018 |
HG Management | Management | 2018 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandlægerne i Haderslev I/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette Ribergård Fischer | Management | 0 companies |
| Helle Gamst Skov | Management | 0 companies |